Evogliptin
id:
evogliptin-322-5304803
title:
Evogliptin
text:
Evogliptin is an antidiabetic drug in the dipeptidyl peptidase-4 (DPP-4) inhibitor or "gliptin" class of drugs. It was developed by the South Korean pharmaceutical company Dong-A ST and is approved for use in South Korea and Russia. In a meta-analysis involving data from 6 randomized controlled trials, Dutta et. al. demonstrated the good glycaemic efficacy and safety of this medicine as compared to other DPP4 inhibitors like sitagliptin and linagliptin.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Evogliptin
date created:
date modified:
2024-03-22T16:28:17Z
main entity:
{"identifier":"Q25103700","url":"https://www.wikidata.org/entity/Q25103700"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c5/Evogliptin.svg","width":1480,"height":870}
fields total:
13
integrity:
15